Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.

Recursion Pharmaceuticals' Chief Medical Officer, Mauro David J, completed a sale of 14,146 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total sale value of $94,636.74. Following the sale, Mauro David J directly holds 229,616 shares in the company. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.